Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Diagnosed with mild cognitive impairment (MCI) in 2018, Mr Almond, from Esher, took part in two 18-month trials for donanemab ...

Expanding public education, increasing access and quality of care, supporting family caregivers and increasing training for ...

This Morning presenter Ruth Langsford has opened up on her fear of developing Alzheimer's disease, having witnessed both her ...

NICE has said the Alzheimer's disease drug is too expensive to be available on the NHS, but researchers are now hoping to ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

If I were a statistician tucked away in an NHS backroom, I might well curse the day the health service was founded. There, on ...

Ruth Langsford said she doesn't fear ageing following her split from Eamonn Holmes and hopes to remain active in the years to ...

The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.View on ...

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

TV presenter Ruth Langsford has spoken out on her ongoing 'fear' of getting a life-changing illness after watching both her ...